Project Grant R01AI187307
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California Santa Cruz a $430,375 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 2, 2026 through March 31, 2028. This award supports investigator-initiated research exploring the bacterial polyadenylase PAP I as a potential antimicrobial drug target. The project delivers scientific research services aimed at...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of California, Berkeley $756,714 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, for a five-year project period concluding March 31, 2031. This Project Grant supports biomedical research investigating the interplay between protein secretion mechanisms and lipid virulence factors in Mycobacterium tuberculosis (MTB) infection and host immune...
- Federal Grant Award Summary The University of California, Santa Barbara received a $410,497 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025 through June 30, 2027. The research project investigates Type 5 secretion as a novel mechanism for delivering protein effectors directly into mammalian host cells, with a specific focus on filamentous hemagglutinin-like...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, San Diego a $3.19 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 16, 2025, with a completion date of June 30, 2029. This grant funds investigator-initiated biomedical research examining the roles and regulation of tissue-resident CD8 T cells during persistent viral infection, utilizing the lymphocytic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $492,000 to The Regents of the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 1, 2025, for a five-year project period concluding July 31, 2030. The award funds biochemical and structural characterization research of the elongasome and divisome protein complexes in Mycobacterium tuberculosis (MTB) and the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $416,005 Project Grant to the University of California Santa Cruz under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 15, 2025, with a completion date of July 31, 2027. This award funds research to establish the structural and molecular basis for human astrovirus (HAstV) entry into human cells, with the ultimate objective of identifying functional sites on...
- Federal Grant Award Summary The University of California, San Diego received a $449,578 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 1, 2026, and completion date of January 31, 2031. This five-year award supports investigator-initiated biomedical research exploring the role of lytic polysaccharide monooxygenases (LPMOs) in the virulence and immunity...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded UC Berkeley a $751,663 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, with a completion date of March 31, 2031. This award funds basic biomedical research aimed at dissecting Shigella pathogenesis through a newly developed physiological oral infection mouse model. The research will utilize NLRC4-deficient mice that exhibit...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of California, Davis a Project Grant totaling $744,328 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 13, 2026. The research will be conducted through January 31, 2031 at UC Davis's campus in Davis, California. This award supports investigator-initiated biomedical research examining the role of trogocytosis (a cell-nibbling mechanism) in the...
- Federal Grant Award Summary The University of California, Merced received a $647,181 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026 through January 31, 2031. The award supports fundamental biomedical research aimed at elucidating the regulatory mechanisms governing inflammasome assembly and activity. Inflammasomes are multiprotein complexes that play...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $810,181 to the University of California Santa Cruz on April 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports a five-year research initiative (concluding March 31, 2031) investigating how bacterial pathogens sense and respond to host environmental cues—specifically iron availability and oxidative stress—to regulate virulence gene expression during infection. The research utilizes Yersinia pseudotuberculosis as a model pathogen to examine how the iron-sulfur (Fe-S) cluster coordinating transcription factor IscR orchestrates regulation of the Type III Secretion System (T3SS) virulence factor in response to cellular Fe-S cluster demand. The grant deliverables include fundamental research findings that will elucidate the molecular mechanisms by which pathogens overcome host defenses during tissue colonization, with particular focus on how IscR strategically overrides H-NS-mediated silencing of horizontally-acquired virulence genes in response to spatiotemporal fluctuations in host iron and oxidative stress. Findings from this investigator-initiated biomedical research are expected to advance scientific understanding of bacterial pathogenesis mechanisms and may inform development of novel therapeutic interventions for infections caused by iron-regulated pathogens, contributing to improved public health outcomes in infectious disease prevention and treatment.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $810.2k | 4/20/26 |